Yearly Archives: 2023

Monoceros Biosystems and SeekIn Join Forces to Pave the Way for Cutting-Edge AI-Powered Cancer Diagnostics

San Diego, September 21, 2023 – Monoceros Biosystems, a prominent [...]

By |2023-09-21T17:29:39+00:00September 21st, 2023|News|Comments Off on Monoceros Biosystems and SeekIn Join Forces to Pave the Way for Cutting-Edge AI-Powered Cancer Diagnostics
Read More

MRTX1719 is an MTA-cooperative PRMT5 inhibitor that exhibits synthetic lethality in preclinical models and patients with MTAP deleted cancer

Mirati Therapeutics, in collaboration with Monoceros Biosystems and leading academic [...]

By |2023-09-11T20:43:00+00:00August 8th, 2023|News|Comments Off on MRTX1719 is an MTA-cooperative PRMT5 inhibitor that exhibits synthetic lethality in preclinical models and patients with MTAP deleted cancer
Read More
Go to Top